CRT Response Prediction Index (QRS + Mechanical Dyssynchrony)

Clinical calculation support · Verify results before clinical use

Electrical and mechanical measurements

Enter measurements in milliseconds. Use the same mechanical dyssynchrony method consistently and document it in the clinical record.

2Inputs
Measure on a 12-lead ECG; enter the duration in milliseconds (for example, 150).
Enter the delay produced by your selected imaging method (e.g., a specified TDI-derived or interventricular delay). These measures are not interchangeable; record the method.
Reset

About this index

This tool combines QRS duration and a user-entered mechanical dyssynchrony measurement using a simple, transparent weighted formula. It is an educational or exploratory index only. It is not a validated CRT response score and should not determine eligibility for cardiac resynchronization therapy.

Formula used

ComponentNormalizationWeight
QRS duration(QRS − 80) / 80, bounded to 0–160%
Mechanical delayMD / 100, bounded to 0–140%

The weighted sum is multiplied by 100 and rounded to the nearest integer. The displayed tiers are the original tool's pragmatic cutoffs: below 40, 40–69, and 70 or above. These cutoffs are not clinically validated thresholds.

Clinical context and limitations

  • CRT selection should primarily follow current guideline recommendations and the complete clinical context, including LVEF, symptoms despite guideline-directed medical therapy, QRS morphology and duration, rhythm, and comorbidities.
  • Mechanical dyssynchrony measurements depend on the imaging method and should not be treated as interchangeable or as a validated substitute for ECG-based selection.
  • A low index must not be used to deny CRT when a patient otherwise meets guideline-based criteria. A high index must not be used as proof of benefit.

Evidence and references

2023 HRS/APHRS/LAHRS Guideline on Cardiac Physiologic Pacing

Guideline discussion notes that ECG QRS duration and morphology remain central to CRT selection; available mechanical dyssynchrony measures have not demonstrated sufficient predictive power to improve selection beyond current guideline criteria.

Read guideline (PMC)
Ruschitzka F, et al. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex.

N Engl J Med. 2013;369:1395–1405. doi:10.1056/NEJMoa1306687.

In EchoCRT, CRT did not reduce death or HF hospitalization in patients with QRS duration under 130 ms and echocardiographic dyssynchrony; mortality was higher in the CRT group.

Read article
Clinical disclaimer: For education and exploratory calculation only. This composite index is not externally validated, is not a calibrated probability of CRT response, and is not a guideline-endorsed selection tool. Do not use it as the sole basis for diagnosis, treatment, device implantation, or exclusion from therapy.